Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans

Abstract

The interleukin 7 receptor alpha single nucleotide polymorphism rs6897932 was identified as a multiple sclerosis susceptibility-modifying polymorphism in genome-wide and gene scan studies, mainly in populations in western countries.

The aim of this study was to investigate the association of interleukin 7 receptor alpha rs6897932 with multiple sclerosis in populations from the Western Balkans: Serbia, Croatia, and Slovenia.

A total of 678 unrelated white patients and 597 unrelated, ethnically matched healthy controls were included in the study. Genotyping was performed by real-time polymerase chain reaction.

We found no significant difference in genotype or allele frequencies between controls and patients with multiple sclerosis either separately in Serbian, Croatian, and Slovenian populations or in the whole sample from the Western Balkans. The odds ratio for multiple sclerosis in this study was 1.04 (0.86—1.25) for the C allele.

It is known that demographic as well as environmental factors have a substantial role in multiple sclerosis development, as well as population genetic background. The results of this study indicate that other types of genome variants should be required for the development and/or progression of multiple sclerosis, which may vary among populations.

Keywords

Interleukin 7 receptor-alpha rs6897932 gene polymorphism multiple sclerosis Western Balkans

Get full access to this article

View all access options for this article.

References

Kaech SM , Tan JT , Wherry EJ , Konieczny BT , Surh CD , Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4: 1191-1198.

Pellegrini M. , Bouillet P. , Robati M. , Belz GT , Davey GM , Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004; 200: 1189-1195.

Mazzucchelli R. , Durum SK Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007; 7: 144-154.

Goodwin RG , Friend D. , Ziegler SF , et al. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor super-family. Cell 1990; 60: 941-951.

Teutsch SM , Booth DR , Bennetts BH , Heard RN , Stewart GJ Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis . Eur J Hum Genet 2003; 11: 509-515.

Gregory SG , Schmidt S. , Seth P. , et al. Multiple Sclerosis Genetics Group. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis . Nat Genet 2007; 39: 1083-1091.

Zhang Z. , Duvefelt K. , Svensson F. , et al. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun 2005; 6: 145-152.

Hafler DA , Compston A. , et al. International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.

Lundmark F. , Duvefelt K. , Iacobaeus E. , et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007 ; 39: 1108-1113.

10.

O’Doherty C. , Kantarci O. , Vandenbroeck K. IL7RA polymorphisms and susceptibility to multiple sclerosis. N Engl J Med 2008; 358: 753-754.

11.

Weber F. , Fontaine B. , Cournu-Rebeix I. , et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun 2008; 9: 259-263.

12.

Akkad DA , Hoffjan S. , Petrasch-Parwez E. , Beygo J. , Gold R. , Epplen JT Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients . J Autoimmun 2009; 32: 110-115.

13.

Poser CM , Paty DW , Scheinberg L. , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.

14.

McDonald WI , Compston A. , Edan G. , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.

15.

Lublin FD , Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.

16.

Roxburgh RH , Seaman SR , Masterman T. , et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.

17.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.

18.

Alcina A. , Fedetz M. , Ndagire D. , et al. The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis. Tissue Antigens 2008; 72: 158-161.

19.

International Multiple Sclerosis Genetics Consortium (IMSGC). Refining genetic associations in multiple sclerosis. Lancet Neurol 2008; 7: 567-569.

20.

Dincić E. , Zivković M. , Stanković A. , et al. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population. J Neuroimmunol 2006; 177: 146-150.

21.

Heggarty S. , Suppiah V. , Silversides J. , et al. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland. J Neuroimmunol 2007; 187: 187-191.